The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Guillain-Barré Syndrome Following Influenza Vaccination
Abstract
CONTEXT: An unexplained increase in the risk of Guillain-Barre syndrome (GBS) occurred among recipients of the swine influenza vaccine in 1976-1977. Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990. OBJECTIVE: To evaluate trends of reports to VAERS of GBS following influenza vaccination in adults. DESIGN, SETTING, AND PARTICIPANTS: VAERS is the US national spontaneous reporting system for adverse events following vaccination. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and US census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details. MAIN OUTCOME MEASURE: Reporting rates of GBS following influenza vaccination over time. RESULTS: From July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in adults. The median onset interval (13 days) was longer than that of non-GBS reports of adverse events after influenza vaccine (1 day) (P<.001). The annual reporting rate decreased 4-fold from a high of 0.17 per 100,000 vaccinees in 1993-1994 to 0.04 in 2002-2003 (P<.001). A GBS diagnosis was confirmed in 82% of reports. Preceding illness within 4 weeks of vaccination was identified in 24% of reported cases. CONCLUSIONS: From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased. The long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine. These findings require additional research, which can lead to a fuller understanding of the causes of GBS and its possible relationship with influenza vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCHONBERGER, L. B., BREGMAN, D. J., SULLIVAN-BOLYAI, J. Z., KEENLYSIDE, R. A., ZIEGLER, D. W., RETAILLIAU, H. F., EDDINS, D. L., & BRYAN, J. A. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112795 · Cited by 785
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
The healthcare cost and utilization project: an overview.
Steiner, C., Elixhauser, A., & Schnaier, J. A. (2002) · PubMed · Cited by 568
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 505
Self-citationPrinciples & Practice of Public Health Surveillance
Lee, L. M., Teutsch, S. M., Thacker, S. B., & St. Louis, M. E. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195372922.001.0001 · Cited by 490
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Zhou, W., Pool, V., Iskander, J. K., English-Bullard, R., Ball, R., Wise, R. P., Haber, P., Pless, R., Mootrey, G. T., Ellenberg, S. S., et al. (2003) · PubMed · Cited by 400
Self-citationThe Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
VARRICCHIO, F., ISKANDER, J., DESTEFANO, F., BALL, R., PLESS, R., BRAUN, M. M., & CHEN, R. T. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00002 · Cited by 380
LANGMUIR, A. D., BREGMAN, D. J., KURLAND, L. T., NATHANSON, N., & VICTOR, M. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113809 · Cited by 238
Cited by
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
van Doorn, P. A., Ruts, L., & Jacobs, B. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70215-1 · Cited by 828
Sejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A., Bakshi, N., Baxter, R., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 652
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
Adverse reactions to vaccines practice parameter 2012 update
Kelso, J. M., Greenhawt, M. J., Li, J. T., Nicklas, R. A., Bernstein, D. I., Blessing-Moore, J., Cox, L., Khan, D., Lang, D. M., Oppenheimer, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.003 · Cited by 293
Metadata
- Authors
- Haber, P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-11-24
- Volume
- 292
- Issue
- 20
- Pages
- 2478
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2033083070
- Cited by
- 254
- References
- 19
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guillain-Barré Syndrome Following Influenza Vaccination. https://app.cochat.ai/papers/10.1001/jama.292.20.2478
- The paper
- Haber, P. (2004). Guillain-Barré Syndrome Following Influenza Vaccination. JAMA. https://doi.org/10.1001/jama.292.20.2478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.